RADIOLIGAND BINDING-STUDIES REVEAL MARKED SPECIES-DIFFERENCES IN THE VASOPRESSIN-V(1) RECEPTOR OF RAT, RHESUS AND HUMAN TISSUES

被引:72
作者
PETTIBONE, DJ [1 ]
KISHEL, MT [1 ]
WOYDEN, CJ [1 ]
CLINESCHMIDT, BV [1 ]
BOCK, MG [1 ]
FREIDINGER, RM [1 ]
VEBER, DF [1 ]
WILLIAMS, PD [1 ]
机构
[1] MERCK SHARP & DOHME LTD,DEPT MED CHEM,W POINT,PA 19486
关键词
D O I
10.1016/0024-3205(92)90524-S
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The [H-3]arginine-vasopressin ([H-3]AVP) binding site in rat, rhesus and human liver and nonpregnant human uterus was characterized and contrasted. [H-3]AVP bound with high affinity (K(i) values, 0.2-0.6 nM) to preparations of all tissues studied. Competition binding studies using a series of compounds from three structural classes indicate a marked species difference between the rat and primate liver AVP-V1 site. This site in rhesus and human liver however, is essentially identical, indicating that the rhesus liver is an appropriate surrogate for human tissue. These studies also indicate that the AVP-V1 site of nonpregnant human uterus and human liver is equivalent.
引用
收藏
页码:1953 / 1958
页数:6
相关论文
共 24 条
[1]   INHIBITION OF UTERINE CONTRACTIONS OF PREMATURE LABOR WITH AN OXYTOCIN ANALOG - RESULTS FROM A PILOT-STUDY [J].
AKERLUND, M ;
STROMBERG, P ;
HAUKSSON, A ;
ANDERSEN, LF ;
LYNDRUP, J ;
TROJNAR, J ;
MELIN, P .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (11) :1040-1044
[2]   VASOTOCIN ANALOGS WHICH COMPETITIVELY INHIBIT VASOPRESSIN STIMULATED UTERINE ACTIVITY IN HEALTHY WOMEN [J].
AKERLUND, M ;
HAUKSSON, A ;
LUNDIN, S ;
MELIN, P ;
TROJNAR, J .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1986, 93 (01) :22-27
[3]   RECEPTOR LIGANDS WHICH BIND THE OXYTOCIN RECEPTOR WITH SELECTIVITY AND HIGH-AFFINITY - CHEMICAL MODIFICATION OF A STREPTOMYCES-SILVENSIS DERIVED CYCLIC HEXAPEPTIDE [J].
BOCK, MG ;
DIPARDO, RM ;
WILLIAMS, PD ;
PETTIBONE, DJ ;
CLINESCHMIDT, BV ;
BALL, RG ;
VEBER, DF ;
FREIDINGER, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2321-2323
[4]  
CHAN WY, 1986, J PHARMACOL EXP THER, V239, P84
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]  
CLINESCHMIDT BV, 1991, J PHARMACOL EXP THER, V256, P827
[7]  
Embrey M P, 1967, J Obstet Gynaecol Br Commonw, V74, P648
[8]   CYCLIC HEXAPEPTIDE OXYTOCIN ANTAGONISTS - POTENCY-ENHANCING, SELECTIVITY-ENHANCING, AND SOLUBILITY-ENHANCING MODIFICATIONS [J].
FREIDINGER, RM ;
WILLIAMS, PD ;
TUNG, RD ;
BOCK, MG ;
PETTIBONE, DJ ;
CLINESCHMIDT, BV ;
DIPARDO, RM ;
ERB, JM ;
GARSKY, VM ;
GOULD, NP ;
KAUFMAN, MJ ;
LUNDELL, GF ;
PERLOW, DS ;
WHITTER, WL ;
VEBER, DF .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) :1843-1845
[9]   OXYTOCIN AND VASOPRESSIN - DISTINCT RECEPTORS IN MYOMETRIUM [J].
GUILLON, G ;
BALESTRE, MN ;
ROBERTS, JM ;
BOTTARI, SP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06) :1129-1135
[10]   CHARACTERIZATION OF THE HUMAN LIVER VASOPRESSIN RECEPTOR - PROFOUND DIFFERENCES BETWEEN HUMAN AND RAT VASOPRESSIN-RECEPTOR-MEDIATED RESPONSES SUGGEST ONLY A MINOR ROLE FOR VASOPRESSIN IN REGULATING HUMAN HEPATIC-FUNCTION [J].
HOWL, J ;
ISMAIL, T ;
STRAIN, AJ ;
KIRK, CJ ;
ANDERSON, D ;
WHEATLEY, M .
BIOCHEMICAL JOURNAL, 1991, 276 :189-195